Teleflex Incorporated (NYSE:TFX) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. decreased its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 0.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,545,520 shares of the medical technology company's stock after selling 43,876 shares during the quarter. Vanguard Group Inc. owned approximately 11.94% of Teleflex worth $986,992,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. HighTower Advisors LLC grew its holdings in Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock valued at $986,000 after buying an additional 66 shares in the last quarter. Hengehold Capital Management LLC grew its stake in Teleflex by 7.3% during the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock valued at $229,000 after acquiring an additional 88 shares in the last quarter. Exchange Traded Concepts LLC increased its holdings in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares during the last quarter. Isthmus Partners LLC lifted its stake in Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock worth $273,000 after purchasing an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in shares of Teleflex by 2.4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company's stock valued at $888,000 after purchasing an additional 118 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and reduced their target price for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Piper Sandler restated a "neutral" rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $182.63.

Teleflex Trading Up 0.4 %

Teleflex stock traded up $0.57 during trading hours on Wednesday, hitting $140.87. The company had a trading volume of 116,712 shares, compared to its average volume of 582,475. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market cap of $6.53 billion, a P/E ratio of 27.96, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a 50-day moving average price of $157.48 and a two-hundred day moving average price of $188.50. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's payout ratio is 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.